To hear about similar clinical trials, please enter your email below

Trial Title: Interest of a TEteleconsultation of a Psychological Support Nurse on Psychological Distress in Patients With a Primary Malignancy of the Central Nervous System

NCT ID: NCT06485310

Condition: Central Nervous System Cancer
Psychological Distress

Conditions: Official terms:
Nervous System Neoplasms
Central Nervous System Neoplasms

Study type: Interventional

Study phase: N/A

Overall status: Recruiting

Study design:

Allocation: Randomized

Intervention model: Parallel Assignment

Primary purpose: Supportive Care

Masking: None (Open Label)

Intervention:

Intervention type: Other
Intervention name: Teleconsultation for psychological support
Description: Teleconsultation with a nurse for psychological support, after the diagnosis has been announced, before hospitalization for the first treatment (chemotherapy, surgery, radiotherapy) in addition to the standard practice
Arm group label: TELECONSULTATION

Summary: The goal of this clinal trial is to compare the effectiveness of nurse-led teleconsultation with usual care (intervention group) on psychological distress in patients with primary malignant tumors of the central nervous system between diagnosis and first anti-cancer treatment, versus usual care alone (control group). Participants will be randomized into two groups : - group A) intervention: usual care + nurse teleconsultation for psychological support - group B) control: usual care alone Enrolment = Day0 (D0) Participants will : - groups A and B: D0: complete 4 questionnaires (Quality of Life, Screening for Distress, Screening for Anxiety and Depression, Social Support Questionnaire) - Group A : D0+2/4 das : nursing teleconsultation for psychological support - Groups A and B: D0+10days : telephone call to complete the same 4 questionnaires as at inclusion - Group A : D0+15days: semi-directive interview, at home, for voluntary patients.

Detailed description: The expected benefits are as follows: For the patient : - Reduction in pre-treatment psychological distress - Reduced pre-treatment anxiety and depression - Better understanding of disease and treatments - Better adherence to the care proposed in the treatment pathway - Reduced stress during first hospital treatment For healthcare professionals : - Early detection of psychological distress - Early detection of unmet needs and appropriate individualized responses - Establishment of a climate of trust between patient and caregiver - Improved professional practices For the healthcare system : - Lower healthcare costs (fewer anxiolytic treatments, etc.) - Therapy to be integrated into the treatment pathway of patients with central nervous system cancer - Reduced socio-territorial inequalities in healthcare provision

Criteria for eligibility:
Criteria:
Inclusion Criteria: - aged 18 and over - being treated for a primary malignant tumor of the central nervous system (positive biopsy) - with a Mini-Mental State score greater than 24 - not receiving first-line treatment (chemotherapy, targeted radiotherapy, surgery) - with a distress score above 3 on the Psychological Distress Thermometer - have access to computer equipment equipped with a microphone and webcam (smartphone, computer) - able to read, write and speak French - have given free and informed consent - being affiliated to a social security scheme Exclusion Criteria: - with a history of psychiatric illness - with recurrent cancer of the cerebral nervous system - having begun first-line treatment (drug therapy, curative surgery, radiotherapy or palliative care) - under guardianship, curatorship or deprived of liberty

Gender: All

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: University Hospital of Reunion Island - Neurosurgery department

Address:
City: St Pierre
Zip: 97410
Country: France

Status: Recruiting

Contact:
Last name: Stephanie FAIDERBE, nurse

Phone: 0262 262 35 91 31
Email: stephanie.federbe@chu-reunion.fr

Start date: December 24, 2024

Completion date: January 31, 2027

Lead sponsor:
Agency: Centre Hospitalier Universitaire de la Réunion
Agency class: Other

Source: Centre Hospitalier Universitaire de la Réunion

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT06485310

Login to your account

Did you forget your password?